Patient info Open main menu

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: With or without prescription Details

Medicine strength:
180 mg
Contains active substance:

Patient leaflet - Fexofenadine Hydrochloride 180 mg film-coated tablets

what it is used for

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets contains fexofenadine hydrochloride, which is a non-drowsy antihistamine.

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets is used in adults and adolescents of 12 years and older to relieve the symptoms that occur with long-term allergic skin reactions (chronic idiopathic urticaria) such as itching, swelling and rashes.

2.

What you need to know before you take

Fexofenadine Hydrochloride

Do not use Fexofenadine Hydrochloride:

•

If you are allergic to fexofenadine or any of

the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Fexofenadine hydrochloride if:

•

you have problems with your liver or kidneys

•

you have or ever had heart disease, since

this kind of medicine may lead to a fast or irregular heart beat

•

you are elderly

If any of these apply to you, or if you are not sure, tell your doctor before taking Fexofenadine hydrochloride.

Children and adolescents

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets is not recommended for children less than 12 years of age.

In children from 6 to 11 years of age: fexofenadine hydrochloride 30 mg tablet is the appropriate formulation for administration and dosing in this population.

Other medicines and Fexofenadine Hydrochloride

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If you are taking apalutamide (a medicine to treat prostate cancer), as the effect of fexofenadine may be decreased.

It is especially important to talk to your doctor before you take fexofenadine if you are also taking any of the following medicines:

-

an antibiotic used to treat certain bacterial infections (erythromycin).

-

an antifungal used to treat fungal infections

(ketoconazole).

These medicines increase the amount of fexofenadine absorbed.

Indigestion remedies containing aluminium and magnesium may affect the action of fexofenadine by lowering the amount of medicinal product absorbed.

It is recommended that you leave about 2 hours between the time that you take Fexofenadine Hydrochloride and your indigestion remedy.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take fexofenadine hydrochloride if you are pregnant, unless recommended by your doctor.

Fexofenadine Hydrochloride is not recommended during breast-feeding.

Driving and using machines

Fexofenadine Hydrochloride is unlikely to affect your ability to drive or operate machinery. However, you should check that these tablets do not make you feel sleepy or dizzy before driving or operating machinery.

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets contain Sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially ‘sodium-free’.

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets contain Lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3.

How to take Fexofenadine Hydrochloride

Dosage

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

For adults and children aged 12 years and over

The recommended dose is one tablet (180 mg) daily. Take your tablet with water before a meal. This medicine starts to relieve your symptoms within 1 hour and lasts for 24 hours.

If you take more Fexofenadine Hydrochloride than you should

If you take too many tablets, contact your doctor or pharmacist or the nearest hospital emergency department immediately. Symptoms of an overdose in adults are dizziness, drowsiness, fatigue and dry mouth.

P15xxxxx

Version: 06

Date & Time: 08.12.2025 & 5.10 pm

Submission: N17883_u10f

If you forget to use Fexofenadine Hydrochloride

Do not take a double dose to make up for a forgotten tablet. Take the next dose at the usual time as planned.

If you stop using Fexofenadine Hydrochloride

If you stop taking Fexofenadine Hydrochloride your symptoms may return.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately and stop taking Fexofenadine Hydrochloride if you experience:

•

swelling of the face, lips, tongue or throat and

difficulty breathing, as these may be signs of a serious allergic reaction.

The following undesirable effects have been reported in clinical trials, with an incidence similar to those observed in patient who did not receive the drug (placebo).

Common side effects (may affect up to 1 in 10 people):

•

headache

•

drowsiness

•

feeling sick (nausea)

•

dizziness

Uncommon side effects (may affect up to 1 in 100 people):

•

tiredness

•

sleepiness

Additional side effects (frequency not known: cannot be estimated from the available data) which may occur are:

•

difficulty sleeping (insomnia)

•

sleeping disorders

•

bad dreams

•

nervousness

•

fast or irregular heartbeat

•

diarrhoea

•

skin rash and itching

•

hives

•

serious allergic reactions which can cause

swelling of the face, lips, tongue or throat, flushing, chest tightness, and difficulty breathing

•

blurred vision

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5.

How to store Fexofenadine Hydrochloride

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage condition.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6.

Contents of the pack and other

information

What Fexofenadine Hydrochloride Film-Coated Tablets contain

-

The active substance is fexofenadine hydrochloride.

Each film-coated tablet contains 180 mg fexofenadine hydrochloride, which is equivalent to 168 mg of fexofenadine.

  • The other ingredients are:

Tablet core: Croscarmellose sodium, lactose, lactose monohydrate, maize starch, silica, colloidal anhydrous, starch, pregelatinised, stearic acid

Tablet coating: Iron oxide red (E172), iron oxide yellow (E172), hypromellose type 2910 6 mPas (E464), macrogol 400 (E1521), titanium dioxide (E171)

What Fexofenadine Hydrochloride 180 mg Film-Coated Tablets look like and contents of the pack

Film-coated tablet

Peach-coloured, capsule shaped, bevel edge, biconvex film-coated tablets debossed with “FE” on one side and “180” on other side.

Fexofenadine Hydrochloride 180 mg Film-Coated Tablets are available in blister and HDPE bottle packs.

Pack sizes:

Blister packs: 7, 15, 20, 30, 50, 60 and 100 film-coated tablets

HDPE pack: 500 film-coated tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Milpharm Limited

1 Roundwood Avenue,

Stockley Park,

Uxbridge,

UB11 1AF

United Kingdom

Manufacturer

APL Swift Services (Malta) Limited

HF26, Hal Far Industrial Estate, Hal Far

Birzebbugia, BBG 3000

Malta

Generis Farmaceutica, S.A.,

Rua Joao De Deus, N 19, Venda Nova,

Amadora, 2700-487, Portugal.

Milpharm Limited

1 Roundwood Avenue,

Stockley Park,

Uxbridge,

UB11 1AF

United Kingdom

This leaflet was last revised in 10/2025.

P15xxxxx

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 16363/0837

Last revision stated in the text: October 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Fexofenadine Hydrochloride 180 mg film-coated tablets

Prescription needed? Depends on the pack size: pharmacy medicine (P) – sold only in pharmacies, prescription-only medicine (POM)
Active substance Fexofenadine
Strength 180 mg
Pharmaceutical form Oral tablet
Peach coloured capsule shaped film-coated tablet of 17.10 mm x 7.60 mm x 5.30 mm, debossed as ‘180’ on one side and ‘FX’ on other side.
How is it taken Oral
Excipients Lactose monohydrate, Low-substituted hydroxypropylcellulose, Pregelatinised starch, Colloidal anhydrous silica, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Hypromellose,, Povidone,, Titanium dioxide,, Iron oxide Red,, Iron oxide Yellow, Macrogol 400
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months.
Storage This medicinal product does not require any special storage condition.
Drug group (ATC) Antihistamines for systemic use
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AX Other antihistamines for systemic use
          1. R06AX26 fexofenadine
Marketing authorisation PL 16363/0837, PL 49445/0123 (first authorised 4 June 2021)
Marketing authorisation holder Amarox Limited
Codes BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.